0
edits
Changes
no edit summary
<td bgcolor="#cccccc"><strong> CD169</strong></td>
<td bgcolor="#cccccc"> 220</td>
<td bgcolor="#cccccc"> SIGLEC-1 (sialic acid ctin-1); Sialoadhesion</td> <td bgcolor="#cccccc"> Macrophages </td> <td bgcolor="#cccccc"> Mediates cell-cell interactions by binding to sialylated ligands on neutrophils, monocytes, NK cells, B cells, and a subset of CD8+ T cells </td>
</tr>
<tr>
<td><strong> CD170</strong></td>
<td> 140</td> <td> SIGLEC-5 (sialic acid binding Ig-like lectin-1) </td> <td> Relatively high levels on neutrophils </td> <td> May be involved in sialic acid-dependent cell-cell interactions </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD171</strong></td>
<td bgcolor="#cccccc"> 200-230</td> <td bgcolor="#cccccc"> L1 cell adhesion molecule </td> <td bgcolor="#cccccc"> Low to intermediate expression on human lymphoid and myelomonocytic cells including CD4+ T cells, a subset of B cells, monocytes, monocyte-derived dendritic cells, many cells of the central and peripheral nervous system </td> <td bgcolor="#cccccc"> Cell adhesion molecule that plays a role in the maintenance of pymph node architecture during an immune response </td>
</tr>
<tr>
<td><strong> CD173</strong></td>
<td> </td>
<td> H2, blood group O antigen </td> <td> Among hematopoietic cells, present on erythrocytes and CD34+ hematopoietic precursors </td> <td> Glycoprotein-borne oligosaccharide </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD174</strong></td>
<td bgcolor="#cccccc"> </td>
<td bgcolor="#cccccc"> Lewis Y blood group antigen</td> <td bgcolor="#cccccc"> Among hematopoietic cells, present on erythrocytes and CD34+ hematopoietic precursors </td> <td bgcolor="#cccccc"> Glycoprotein-borne oligosaccharide </td>
</tr>
<tr>
<td><strong> CD177</strong></td>
<td> 58-64</td> <td> NB1 </td> <td> Surfaces and secondary granules of neutrophils</td> <td> Glycoprotein </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD178</strong></td>
<td bgcolor="#cccccc"> Monomer of cell surface form 40; soluble forms 26-30</td> <td bgcolor="#cccccc"> Fas ligand, FasL</td> <td bgcolor="#cccccc"> Constitutive or induced expression on many cell types including T cells, NK cells, microglial cells, neutrophils, nonhematopoietic cells such as retinal and corneal parenchymal cells </td> <td bgcolor="#cccccc"> Not known </td>
</tr>
<tr>
<td><strong> CD179a</strong></td>
<td> 16-18</td> <td> VpreB </td> <td> Selectively expressed in pro-B and early pre-B cells </td> <td> Associates with CD 179b to form surrogate light chain if the preB cell receptor </td>
</tr>
<tr>
<td bgcolor="#cccccc"><strong> CD179b</strong></td>
<td bgcolor="#cccccc"> 22</td> <td bgcolor="#cccccc"> Lambda5 </td> <td bgcolor="#cccccc"> Selectively expressed in pro-B and early pre-B cells </td> <td bgcolor="#cccccc"> Associates with CD 179a to form surrogate light chain if the preB cell receptor </td>
</tr>
<tr>
<td><strong> CD180</strong></td>
<td> 95-105</td> <td> RP105, LY64 </td> <td> Monocytes, dendritic cells, mantle zone B cells </td> <td> Not known </td>
</tr>
</tbody>
</table>